Tiltan Pharma

Develops therapeutics for treatment of metastatic pancreatic cancer using combinatorial drug therapy technology

placeJerusalem, Jerusalem District, Israel calendar_todayFounded 2006 language tiltanpharma.com

Innovation

9 patent families (2 granted) — focus: Human necessities; filing pace dormant. Cited 80 times.

YearFilings
20122
20132
20142
20151
20161
20171
20181

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital267%
Private equity133%
Coming soon